450 Trial in progress: A phase 1b study of alrizomadlin, alone or plus 5-azacitidine or cytarabine, in pts with relapsed/refractory acute myeloid leukemia and relapsed higher-risk myelodysplastic syndrome - Yifan Zhai; Jianxiang Wang (Journal for ImmunoTherapy of Cancer, 2021)